Eli Lilly, Amgen and More Big Pharma Earnings to Look For This Week

Insider buying can be an encouraging signal for potential investors. The new earnings season has closed buy windows for many insiders. Some insiders made purchases after quarterly results were posted. read more.....»»

Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports......»»

Biotech stocks continued to langu.....»»

Biotech stocks continued to languish for a third straight week. Negative broader market sentiment and company-specific weakness weighed down on the sector. read more.....»»

The earnings season is in full swing, with a number of companies are expected to report results this week. Here is a short ov.....»»

The earnings season is in full swing, wit.....»»

Biotech stocks went about in a steady manner this week amid a slew of big pharma and biotech earnings announcements, a handful of FDA approvals and a few clinical trial readouts. Lexicon Pharmaceuticals, Inc. read more.....»»

Biotech stocks went about in a steady manner this week amid a slew of big pharma and biotech earnings announcements, a handful of FDA approvals and a few clinical trial readouts. Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) was a huge casualty a.....»»

Biotech stocks had a relatively muted performance last week. Johnson & Johnson (NYSE: JNJ) kick started the second-quarter reporting season for big read more.....»»

Biotech stocks had a relatively muted performance last week. Johnson & Johnson (NYSE: JNJ) kick started the second-quarter reporting season for big pharma companies, beating forecasts a.....»»

Last week was a quiet one for the biotech space with the exception of a few clinical trial readouts. Pharma and biotech stocks took comfort in a ruling by a federal judge that went against President Donald Trump's initiative that.....»»

Last week was a quiet one for the biotech space with the exception of a few clinical trial readouts. read more.....»»

24/7 Wall St. reviews dozens of analyst research reports each day of the week to find new ideas for investors and traders alike. Some of these analyst reports cover stocks to buy, while others cover........»»

Biotech stocks staged a recovery this week after being in the red in the previous two weeks. AbbVie Inc (NYSE: ABBV)'s psoriasis drug Skyrizi received FDA nod. The week also saw the release of strong quarterly earnings by big European pharma gian.....»»

Biotech stocks witnessed a slowdown in momentum last week, which was a relatively slow one in terms of news flow. Amgen, Inc. read more.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech Stocks Hitting 52-week highs on April 24) read more.....»»

Earnings season continues this week with reports from Caterpillar Inc. (NYSE: CAT), Eli Lilly and Co. (NYSE: LLY) and Boeing Co. (NYSE: BA). CAT and LLY both report before market open on Tuesda.....»»

Earnings season continues this week with reports from Caterpillar Inc. (NYSE: CAT), Eli Lilly and Co. (NYSE: LLY) and Boeing Co. (NYSE: BA). CAT and LLY both report before market open on Tuesday, Apr. 24. read more.....»»

Below is a list of notable corporate events for the week beginning June 18. Note, this list is not comprehensive and all dates are subject to change. All times are ET. Monday Conferences Blockchain Economic Forum June 16-19 FDA/Biotech Latest Rat.....»»

24/7 Wall St. has put together a preview of AbbVie, Eli Lilly, Gilead Sciences and some of the other, larger health care companies that are about to report their quarterly results......»»